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Abstract   
The purpose of the work is to show that it is possible to rehabilitate 
with  Multifatorial Regenerative Protocol (MFRP) also the patients with 
diseases considered to be absolute contraindications  to the implant 
rehabilitation.  
For the rehabilitation it has been used the PBR rehabilitation technique, that 
allows to insert prosthetic roots not excessively traumatizing the bone tissue 
and to avoid the use of high speed rotary burs.  Despite the disease and the 
poor bone quality, it has been possible to obtain the osteo-connection only in 
45 days.   
Using the MFRP implants, it is possible to rehabilitate with a high 
percentage of success also patients with poor bone quality and density.   
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Introduction 
The Gougerot-Sjögren syndrome is a multifactorial chronic 
inflammatory autoimmune disease.    
Described by Sjögren in 1933, it strikes about 2% of the elderly general 
population, affecting mainly females (Giannetti, 2007) compared with males 
with a 9:1 ratio and with the highest incidence in the 40-50 years age bracket 
(Fegis-Marrano-Ruberti,1996).   
 This disease affects the exocrine glands resulting in a progressive 
atrophy that involves a serious secretory insufficiency.    
The Sjögren’s syndrome can be classified as follows:   
1. Primitive form, when it doesn't shows itself associated to another 
autoimmune disease (Moutsopoulos,1980; Youinow and Miossec, 1982). In 
rare cases, the primitive form evolves into a pseudolymphoma (Zulman et 
al., 1979); 
2. Secondary form, when it is associated to other autoimmune diseases 
such as the rheumatoid arthritis, SLE, scleroderma, vasculitides and 
connectivitides.    
The disease’s cause is attributed to a hyperstimulation of the B 
lymphocytes that attacking the glandular acina provoke ingravescent 
sclerosis and finally atrophy of the glandular parenchyme.   
The suffering of the salivary glands is highlighted still further by the 
prominence of the Stensen’s duct exit, parotidean tumefaction and viscous 
secretion.   
Inside the glands one can observe  islands composed of myoepithelial 
cells that have a marked diagnostic significance (Todesco).   
The extraglandular symptoms caused by the Sjögren’s  syndrome are 
various and they  strike various organs and can be summarized and arranged 
as follows (Tab 1) (Zoppini, 1996).     
The diagnostic safety of Sjögren’s syndrome it is made through 
particular examinations that appraise the exocrine glands functionality.   
The examinations that are usually carried out are:   
- rheumatological examination;   
- Shirmer’s test, that examines the health condition of the lacrimal 
glands measuring the production of tears;   
- Saxon text: that measures the saliva production and accordingly 
determines the degree of compromission of the salivary glands.    
- sialolithography, scintigraphy, echography, MR or sialoresonance in 
the most particular cases;   
- biopsy of the minor salivary glands (of the lower lip) and 
histological examination through  which it is appraised the degree of 
infiltration of the inflammatory cells in the salivary glands   
- hemochrome, in which there is the reduction of the leukocytes;   
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- ESR (in the patients suffering from the syndrome there is an 
increase of ESR) PCR, creatinine, ANA autoantibodies (antinuclear 
antibodies), anti-ENA (anti-SSA and anti-SSB) count and detection of 
rheumatoid factor;    
- complete urine examination to appraise the possible pathological 
involvement of the urinary system.  
There is only a symptomatic therapy with the application of artificial 
tears, emollient mouthwashes, frequent liquid intake. To deal with the 
systemic symptomatology instead it is indicated the use of corticosteroids, 
immunosuppressors, FANS.   
 
Material And Methods 
Clinical Case N°1    
The patient M.A., female, age 60 years old, non smoking, discovered 
the first systemic symptom of the disease when she was 20 years old with the 
manifestation of the Raynaud’s phenomenon, both in the hands and in the 
feet.   
The patient, always when she was 20 years old,  underwent to 
successful appendectomy surgery. When she was 24 years old underwent 
cholecystostomy and the next year she underwent to surgery to remove a 
breast nodule.   
The pathological interest of the salivary glands, that provoke 
poor/low salivary secretion, showed itself for the first time when she was 45 
years old. The salivary glands show themselves partially. The parotidean 
region is periodically interested by tumefaction phenomenona that are fought 
/cured/treated with the administration of antibiotics and cortisone.    
It has been suspected a bilateral benign breast cancer because the 
nodules that were present there tend to grow, but the endocrinologist 
contradicted the diagnosis, showing that with homeopathic treatment with 
arnica lymphomyosot and spongia tosta (OTI - Boiron) the dimensions of the 
nodules decreased. The homeopathic treatment had also a positive action on 
the cheek tumefaction, whose showing frequency decreased.     
At clinical examination the patient’s oral and cheek mucosa and the 
tongue, both in the ventral and dorsal aspect, did not show signs of 
pathology.    
The patient underwent pre-operative OPT radiography as a 
preventive measure (Fig.1).   
Both at clinical examination and at radiological examination the 
maxillary bone quantity was satisfactory in the vertical dimension but instead 
very poor in the horizontal dimension.   
By taking advantage of these characteristics and of the good elasticity 
that in general shows the maxillary bone, it has been decided to rehabilitate 
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the patient with implant fixtures using the split crest technique (Osborne, 
1984).   
The rehabilitation of the site was carried out following the MFRP 
guidelines (Corigliano et al, 2001, 2005, 2006, 2010).   
The surgical site was treated with ozone as a preventive measure in 
order to reduce the levels of bacterial colonization and hyper-oxygenate the 
site.   
After the design of a suitable flap and having undermined the tissue 
the full thickness with a split crest chisel one incises the bone crest to create 
the needed bone gap for the insertion and the primary stability of  the 
prosthetic roots (Fig.2-3).   
After the separation of the palatal and vestibular cortical plates it 
begins the real preparation of the implant site with the initial use of a 3.7mm 
probe (TMI,Italy) at 40 rpm to ascertain/determine the depth of the work and 
then completed with the special expander.     
The definitive form of the implant site was carried out with the 
UNICA osteotome (TMI,Italy) used  below 60 rpm without irrigation.   
In total, in the whole maxillary arch, 7 prosthetic roots were inserted 
(TMI,Italy), having all excellent primary stability in the zones 12,13,15,17, 
23, 26, 27. (Fig.4-5).   
The defects in two walls that did form in consequence of the insertion 
of the fixtures were filled with autologous bone (Fig.6).   
The autologous bone inserted into the bone defects has been obtained 
directly from the surgical site during the preparation of the implant sites 
thanks to the particular design of the working part of the UNICA osteotome 
(TMI,Italy) (Fig.7).   
The autologous material is protected with a fibrin membrane obtained 
from the venous blood of the patient, thanks to a blood phase separator 
VLAD (TMI,Italy) and pericardium resorbable membrane (Osteobiol, Roen). 
With the same MFRP technique it has been possible to rehabilitate 
also the lower arch. (Fig.8-9)  
In the lower quadrants it has been possible to insert 4 fixtures, fairly 
distributed among the 2 quadrants 35,36,45,46 avoiding the mandibular 
nerve following the AANT technique (Corigliano, Baldoni, 2007).   
In the post-operative course the patient underwent to Combined 
Magnetic Fields (CMFs) (Crescentini et al, 2008,2010,2011) . 
 
Clinical Case N°2 
Pazient C.E, fermale, age 74 years old, no smoking, suffering from 
hypertension, chronic obstructive pulmonary disease, gallstones and 20 years 
of Sjogren's syndrome. 
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On physical examination, the oral mucosa was glossy and dry with 
difficulty in speech. 
There were no major signs of pathology, however, either in oral 
mucosa or on the dorsal and ventral surfaces of the tongue. 
During the first visit, was submitted to radiographic OPT (Fig. 10) to 
assess the state of health of the bone structure and the Vertical Dimension. 
After the clinical examination and radiological, the rehabilitation 
technique considered more appropriate for the rehabilitation was the 
overdenture. 
Even for the rehabilitation of this case, we have followed the dictates 
of MFRP. 
In the pre-surgical phase the implant site was treated with ozone to 
break down the bacterial load and iper-oxygen the site. 
There have been two micro incisions lozenge in area 43-44 with 
minimum detachment of periosteum to minimize bleeding and  bone 
resorption. 
The implant site preparation in area 44 was made initially using the 
probe 3.7 mm (TMI, Italy) and subsequently completed with an rotating 
osteotome UNICA 3.7 mm (TMI, Italy) followed by insertion of a 
prosthetical root 3,7 x13 mm (TMI, Italy). 
On the site 43 instead, the implant site was prepared with 4.2 mm 
probe and completed with the osteotome UNICA 4.2 mm to accommodate a 
fixture 4,2 x13 mm (TMI, Italy). 
To improve the osteoconnection of the prosthesic roots, they were 
covered with a thin layer of fibrin obtained from patient’s venous blood. 
After the surgery, it was made a radiograph OPT control (Fig.11). 
Also this patient, was treated with CMF, in the post-surgical phase. 
After 60 days, the implants were loaded permanently. 
 
Results 
In the first case, at radiographic follow-up at 45 days it has been 
observed that, despite the disease, the implants were osteo-connected to the 
surrounding bone without signs of suffering (Fig.12).   
Finally, it has been carried out a radiographic examination with the 
loaded final prosthesization (Fig.13) with an optimal aesthetic result 
(Fig.14).   
Clinical and radiographic follow-up of the second case, after 60 days 
and after 48 months, indicate how the fixtures were well osteo-connected to 
the bone with no signs of pathology. (Fig.15-16) 
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Conclusion 
The Sjogren's syndrome is a chronic inflammatory autoimmune 
disease that affects a growing number of individuals. It is increasingly 
common to meet them as patients in a dental clinic, due to the effects of this 
disease on the masticatory apparatus. 
Approximately 90% of patients with Sjogren syndrome are fermale 
(Scully, 1986) and all patients in the present study were fermale. 
 In almost all cases, patients present few dental elements and almost 
completely destroyed by destructive caries. 
With the traditional techniques, rehabilitation is very difficult and in 
most cases the attempts end with failures. 
The two described cases, show that the satisfaction of the edentulous 
patients suffering from the Sjögren’s syndrome rehabilitated with the new 
protocol it increases compared with a treatment with mucous supported 
prostheses, since the mucous support prostheses, because of the xerostomia, 
provoked problems both of retention and of very annoying inflammations for 
the patient.   
The treatment with MFRP showed itself more reliable also compared 
with the traditional  osseointegrated implant rehabilitation techniques, 
underlining a longer permanence of the 
p r o s t h e t i c roots on the spot.   
In both cases, at a distance of years from the treatment, the prosthetic 
roots are still well integrated in the bone.    
The MFRP is proposed as a novel technique for the treatment of these 
patients particularly complicated with predictable results. 
Thanks to the MFRP technique it is possible to treat also the bone 
defects in patients affected by serious diseases that were considered until 
some time ago as absolute contraindications.   
The wide application fields of this technique are to be attributed to 
the fact that the blood undergoes a particular treatment, that makes 
immediately available to the organism all the growth factors needed for the 
regeneration to which it is then added the help of the physical medicine.   
It was still possible to fabricate prosthetic restorations that 
significantly improved the well-being of the patient. 
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SJÖGREN'S SYNDROME EXTRAGLANDULAR SYMPTOMS OVERVIEW 
Respiratory System - Laryngotracheitis 
- Recurring Bronchitis 
- Lymphocytic Interstitial Pneumonia 
- Pseudolymphoma with nodular 
infiltrates 
- Pleural Effusion 
- Pulmonary Hypertension 
- Lymphoma 
Urinary System - Interstitial Nephritis 
- Tubular acidosis 
- Renal lithiasis 
- Nephrocalcinosis 
- Glomerulonephritis 
Gastrointestinal System - Dysphagia 
- Atrophic Gastritis 
- Primary Biliary Cirrhosis 
- Sclerosing Cholangitis 
- Pancreatitis 
Circulatory and lymphohematopoietic 
system 
- Pseudolymphoma 
- Angioplastic Lymphadenopathy 
- Lymphoma 
- Myeloma 
- Lymphopenia and neutrophilopenia 
- Aplastic Anemia 
Integumentary System - Purpura 
- Raynaud's phenomenon 
- Vasculitides 
Further symptoms - Arthralgias and arthritides 
- Thyroiditides 
- Symmetrical Peripheral Neuropathy 
- Multiple Mononeuritides 
- Myalgias 
Tab. 1 Sjögren's syndrome extraglandular symptoms 
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Fig.1 Pre-operative OPT  radiograph 
 
Fig.2: Chisel used for the incision and 
the stretching apart  of the alveolar bone 
in the quadrant 1. 
 
 
Fig.3: Chisel used for the incision and the 
stretching apart of the alveolar bone  in the 
quadrant 2. 
 
 
 
Fig.4: The prosthetic roots applied in the 
first quadrant in the zone 12, 13, 14, 16. 
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Fig.5 The prosthetic roots applied in the second 
quadrant in the zone 23, 24, 27. 
 
 
 
Fig.6: Autologous bone inserted into the 
bone defects to fill them and the 
membrane applied to cover them. 
 
Fig.7: Autologous bone spicules obtained with 
UNICA osteotome. 
 
 
Fig.8: Probing of the implant site with 
TMI probe in the zone 45-46. 
 
Fig.9: Implant site prepared with UNICA 
osteotome 
 
 
Fig.10: OPT radiograph before surgery 
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Fig.11: Post-operative OPT radiograph 
 
 
 
Fig.12: Post-operative follow-up 
OPT radiograph at 45 days following the 
AANT Techinique (33). 
 
Fig.13: OPT radiograph carried out at 6 months 
 
 
 
Fig.14:. Aesthetic result at the end of the 
rehabilitative therapy 
 
 
Fig.15: Follow-up after 60 days 
 
 
Fig.16: Follow-up OPT after 48 months 
 
 
 
 
 
 
